1. Biomarkers for Predicting the Response to Radiation-Based Neoadjuvant Therapy in Rectal Cancer
   Yuhong Chen et al, 2022, Frontiers in Bioscience-Landmark CrossRef
2. Integrated Analysis Identifies a Nine-microRNA Signature Biomarker for Diagnosis and Prognosis in Colorectal Cancer
   Ziyang Di et al, 2020, Frontiers in Genetics CrossRef
3. Programmed cell death ligand 1 expression on monocytes is inversely correlated with tumour response to preoperative chemoradiotherapy for locally advanced rectal cancer
   Mineyuki Tojo et al, 2022, Colorectal Disease CrossRef
4. microRNAs combined to radiomic features as a predictor of complete clinical response after neoadjuvant radio-chemotherapy for locally advanced rectal cancer: a preliminary study
   Pasquale Losurdo et al, 2023, Surgical Endoscopy CrossRef
5. MicroRNAs in Rectal Cancer: Functional Significance and Promising Therapeutic Value
   Laura Imedio et al, 2020, Cancers CrossRef
6. Can We Reliably Predict a Clinical Complete Response in Rectal Cancer? Current Trends and Future Strategies
   Luis R. Taveras et al, 2018, Current Colorectal Cancer Reports CrossRef
7. The role of upregulated miR-375 expression in breast cancer: An in vitro and in silico study
   Wei Tang et al, 2020, Pathology - Research and Practice CrossRef
8. Biomarkers and cell-based models to predict the outcome of neoadjuvant therapy for rectal cancer patients
   Aylin Alkan et al, 2021, Biomarker Research CrossRef
9. MicroRNA molecular profiling identifies potential signaling pathways conferring resistance to chemoradiation in locally-advanced rectal adenocarcinoma
   Cory Pettit et al, 2018, Oncotarget CrossRef
10. Clinical and molecular diagnosis of pathologic complete response in rectal cancer: an update
    Corey Timmerman et al, 2018, Expert Review of Molecular Diagnostics CrossRef
11. Development of a long non-coding RNA signature for prediction of response to neoadjuvant chemoradiotherapy in locally advanced rectal adenocarcinoma
    Lorenzo Ferrando et al, 2020, PLOS ONE CrossRef
12. Predicting response to neoadjuvant chemoradiotherapy in rectal cancer: from biomarkers to tumor models
    Moying Li et al, 2022, Therapeutic Advances in Medical Oncology CrossRef